Al-Shamkhani A - Search Results

1

Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Slebioda TJ, Rowley TF, Ferdinand JR, Willoughby JE, Buchan SL, Taraban VY, Al-Shamkhani A. Slebioda TJ, et al. Eur J Immunol. 2011 Sep;41(9):2606-11. doi: 10.1002/eji.201141477. Epub 2011 Aug 4. Eur J Immunol. 2011. PMID: 21688261 Free article.

2

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.

al-Shamkhani A, Birkeland ML, Puklavec M, Brown MH, James W, Barclay AN. al-Shamkhani A, et al. Eur J Immunol. 1996 Aug;26(8):1695-9. doi: 10.1002/eji.1830260805. Eur J Immunol. 1996. PMID: 8765008

3

CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice.

Malmström V, Shipton D, Singh B, Al-Shamkhani A, Puklavec MJ, Barclay AN, Powrie F. Malmström V, et al. J Immunol. 2001 Jun 1;166(11):6972-81. doi: 10.4049/jimmunol.166.11.6972. J Immunol. 2001. PMID: 11359859

4

Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.

Haswell LE, Glennie MJ, Al-Shamkhani A. Haswell LE, et al. Eur J Immunol. 2001 Oct;31(10):3094-100. doi: 10.1002/1521-4141(2001010)31:10<3094::aid-immu3094>3.0.co;2-f. Eur J Immunol. 2001. PMID: 11592086 Free article.

5

Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.

Hargreaves PG, Al-Shamkhani A. Hargreaves PG, et al. Eur J Immunol. 2002 Jan;32(1):163-73. doi: 10.1002/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T. Eur J Immunol. 2002. PMID: 11754357 Free article.

6

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.

Taraban VY, Rowley TF, O'Brien L, Chan HT, Haswell LE, Green MH, Tutt AL, Glennie MJ, Al-Shamkhani A. Taraban VY, et al. Eur J Immunol. 2002 Dec;32(12):3617-27. doi: 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M. Eur J Immunol. 2002. PMID: 12516549 Free article.

7

Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.

Rowley TF, Al-Shamkhani A. Rowley TF, et al. J Immunol. 2004 May 15;172(10):6039-46. doi: 10.4049/jimmunol.172.10.6039. J Immunol. 2004. PMID: 15128787

8

CD137: costimulator turns suppressor?

Al-Shamkhani A. Al-Shamkhani A. Immunology. 2004 Sep;113(1):23-5. doi: 10.1111/j.1365-2567.2004.01963.x. Immunology. 2004. PMID: 15312132 Free PMC article. No abstract available.

9

Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs.

Taraban VY, Rowley TF, Al-Shamkhani A. Taraban VY, et al. J Immunol. 2004 Dec 1;173(11):6542-6. doi: 10.4049/jimmunol.173.11.6542. J Immunol. 2004. PMID: 15557144

10

Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming.

Taraban VY, Rowley TF, Tough DF, Al-Shamkhani A. Taraban VY, et al. J Immunol. 2006 Sep 1;177(5):2969-75. doi: 10.4049/jimmunol.177.5.2969. J Immunol. 2006. PMID: 16920932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters